| Pancreatobiliary Carcinoma studied in …STUDIED_INderived200 of 2,131show all (up to 200) |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605913Phase 1/Phase 2 · active not recruiting Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06608927Phase 3 · active not recruiting Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766187Phase 2 · not yet recruiting Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07846267Phase 2 · not yet recruiting Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847710Phase 2 · recruiting Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645160Phase 1/Phase 2 · recruiting Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388967recruiting Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833658NA · completed Effects of Aromatherapy With Essential Oils on Anxiety and Depression in Perioperative Patients With Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595931Phase 1 · active not recruiting M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005493Phase 1/Phase 2 · recruiting Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428409Phase 1/Phase 2 · recruiting A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910670NA · active not recruiting Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989437Phase 2/Phase 3 · recruiting A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562152Phase 3 · recruiting Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670312Phase 1/Phase 2 · recruiting Evaluation of XYA02 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673341Phase 2 · recruiting [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841574Phase 2 · recruiting HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302621Phase 1 · recruiting Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888063Phase 2 · recruiting Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252232Phase 3 · recruiting Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344220Phase 2 · enrolling by invitation Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836777Phase 2 · not yet recruiting Efficacy and Safety of MitoQ in Improving Cancer Cachexia · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291651recruiting UCSF PANC Cyst Registry · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06128551Phase 1/Phase 2 · recruiting Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445062Phase 1/Phase 2 · recruiting Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146646Phase 2 · recruiting Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213791Phase 1 · recruiting A Study of LY4337713 in Participants With FAP-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409272Phase 3 · recruiting A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488676Phase 1/Phase 2 · recruiting A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522476Phase 2 · recruiting A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619521Phase 1/Phase 2 · recruiting Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769502Phase 2 · recruiting A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04512209NA · completed Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543071Phase 2 · active not recruiting Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06271291recruiting Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375915Phase 2 · recruiting Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629960Phase 1/Phase 2 · recruiting A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645651Phase 1 · recruiting Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831330Phase 2 · not yet recruiting Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04638751suspended ARGONAUT: Stool and Blood Sample Bank for Cancer Patients · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435038Phase 1/Phase 2 · recruiting Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07450859Phase 2 · recruiting A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827053Phase 2 · not yet recruiting Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828236Phase 1 · not yet recruiting PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829185Phase 1 · not yet recruiting Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275737NA · recruiting POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349537Phase 1 · recruiting Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824960Phase 1/Phase 2 · not yet recruiting Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic Adenocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07826780NA · not yet recruiting The STRONG Nutrition Support Study for People With Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252545NA · recruiting Promoting CT Engagement for Pancreatic Cancer With App · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06574620NA · recruiting Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02381561Phase 1 · active not recruiting Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05692596active not recruiting The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263088NA · recruiting EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412510Phase 1/Phase 2 · active not recruiting Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255001NA · recruiting Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702292Phase 2 · recruiting [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708067Phase 1 · active not recruiting Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858009Phase 2 · recruiting Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07491445Phase 3 · recruiting Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01585805Phase 2 · active not recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665947early Phase 1 · active not recruiting First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905082NA · active not recruiting HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077800Phase 2 · active not recruiting FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123482Phase 1/Phase 2 · recruiting A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05850130NA · recruiting Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651580recruiting Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081360Phase 3 · recruiting Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132541Phase 1 · recruiting Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148830NA · recruiting Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814586not yet recruiting Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514497Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524973NA · recruiting Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733427NA · not yet recruiting Evaluating the Effectiveness of AIT in the Treatment of Pain Related to Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812805Phase 1 · recruiting SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660971Phase 1 · active not recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212274Phase 2 · active not recruiting Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039892Phase 2 · not yet recruiting Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Adult Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685602Phase 1 · suspended CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968326Phase 2 · active not recruiting A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037980Phase 2/Phase 3 · recruiting CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175845NA · recruiting Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06597721Phase 1 · recruiting ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808671NA · not yet recruiting A Decision Support Tool for Pancreatic Cancer Screening -Aim 2 · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01915225recruiting Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662879NA · active not recruiting Early Detection Initiative for Pancreatic Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861452Phase 1/Phase 2 · recruiting Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805954Phase 3 · recruiting Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806110Phase 2 · active not recruiting Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807956Phase 1 · not yet recruiting A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03608631Phase 1/Phase 2 · recruiting iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04005690early Phase 1 · recruiting Targeted Pathway Inhibition in Patients With Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04340141Phase 3 · active not recruiting Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05372614Phase 1 · recruiting Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050252Phase 2 · suspended Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390059Phase 2 · completed EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803770not yet recruiting EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803783Phase 3 · not yet recruiting A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493060Phase 2 · completed Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05141643early Phase 1 · active not recruiting Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07120295Phase 4 · recruiting Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644559Phase 2 · recruiting A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801027Phase 4 · not yet recruiting A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245500Phase 1 · recruiting Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286814Phase 2 · recruiting PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05506943Phase 2/Phase 3 · active not recruiting A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06673017Phase 1 · recruiting PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06728410Phase 2 · recruiting A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024615Phase 1 · recruiting A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799298NA · not yet recruiting Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02676349Phase 2 · completed Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04172532Phase 1/Phase 2 · recruiting Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526443recruiting Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05727176Phase 2 · recruiting Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305247Phase 1/Phase 2 · active not recruiting A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573215approved for marketing Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796594NA · active not recruiting Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796997Phase 1 · not yet recruiting GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497531NA · recruiting Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084013recruiting Use Of Indocyanine Green In Pancreas Surgery · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632235Phase 1/Phase 2 · not yet recruiting A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793253Phase 2 · not yet recruiting Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06582017Phase 1 · recruiting Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06698458NA · recruiting Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737692NA · completed Effects of Aerobic and Resistance Exercise Training in Individuals With Cancer Cachexia · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227168Phase 1 · recruiting A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630961Phase 1 · recruiting Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640295Phase 1/Phase 2 · recruiting Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157127Phase 1 · recruiting Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07494994NA · not yet recruiting SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07787156NA · not yet recruiting Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206360completed Pancreatic Cancer Early Detection Program · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510740active not recruiting Liver Cancer Registry Platform · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923475Phase 2/Phase 3 · recruiting Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Extrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958328Phase 3 · recruiting Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594626Phase 1/Phase 2 · recruiting BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05517811recruiting Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084481Phase 1 · recruiting Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586515Phase 1 · recruiting MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068194Phase 1/Phase 2 · active not recruiting Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147494early Phase 1 · active not recruiting Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554367Phase 2 · active not recruiting Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843551Phase 2 · recruiting The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04673448Phase 1 · active not recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851106completed Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma. · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274657NA · recruiting Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608458NA · not yet recruiting Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619313Phase 1 · recruiting AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776353recruiting Understanding New Cachexia Subtypes Through Observational Epidemiological Research · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777211Phase 1/Phase 2 · active not recruiting A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550494Phase 2 · active not recruiting Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05220046Phase 1 · completed Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05692323NA · active not recruiting A Supervised Prehabilitation Program for Patients With Pancreatic Cancer · condition mapped ALIAS · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07175389Phase 1/Phase 2 · not yet recruiting JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214298Phase 1/Phase 2 · recruiting Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226154recruiting Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043387recruiting Streamlining Radioembolization for CCC and Metastatic Liver Cancer · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07542041NA · recruiting Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891289Phase 2 · recruiting Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895709Phase 1/Phase 2 · recruiting A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05791448Phase 1 · suspended AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05975593NA · recruiting MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial · condition mapped CURATED_BROADER · 2,131 trials mapped (846 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06048133Phase 2 · active not recruiting Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) · condition mapped ONTOLOGY_EXACT · 2,131 trials mapped (846 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |